ArticleEuropean journal of clinical pharmacology2016

Off-label use of the expensive orphan drug eculizumab in France 2009-2013 and the impact of literature: focus on the transplantation field.

Johann Castañeda-Sanabria et al.PubMed ↗Publisher ↗

No numbers read from the abstract.